<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04267991</url>
  </required_header>
  <id_info>
    <org_study_id>Hamaky5</org_study_id>
    <nct_id>NCT04267991</nct_id>
  </id_info>
  <brief_title>Corneal Densitometry Changes With Adenoviral SEI</brief_title>
  <official_title>Corneal Densitometry Changes With Adenoviral Keratoconjunctivitis Sub Epithelial Infiltrates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benha University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Benha University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adenoviral Sub epithelial infiltrates (SEI) affect ocular function.They lead to reduced
      vision, photophobia, glare, halos, and foreign body sensation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      first group of patients were treated with 0.03 % tacrolimus ointment twice daily for 6
      months.S econd group underwent transepithelial PTK for subepithelial infiltrates. Baseline
      and post-treatment full ophthalmic examination was done.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Actual">April 15, 2020</completion_date>
  <primary_completion_date type="Actual">April 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>changes of corneal densitometry</measure>
    <time_frame>6 months</time_frame>
    <description>Sub epithelial infiltrates was examined with the densitometry programme of the Pentacam (Fa. Oculus,Weimar, Germany)</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">63</enrollment>
  <condition>Corneal Disease</condition>
  <arm_group>
    <arm_group_label>Tacrolimus</arm_group_label>
    <description>Patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phototherapeutic Keratectomy</arm_group_label>
    <description>Patients underwent transepithelial PTK for subepithelial infiltrates.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>patients received only artificial tears eyedrop</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tacrolimus ointment</intervention_name>
    <description>Patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.</description>
    <arm_group_label>Tacrolimus</arm_group_label>
    <other_name>Protopic ointment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phototherapeutic keratectomy</intervention_name>
    <description>Patients underwent transepithelial PTK for subepithelial infiltrates.</description>
    <arm_group_label>Phototherapeutic Keratectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        60 patients with adenoviral SEI
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adenoviral SEI

        Exclusion Criteria:

          -  Other corneal diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>TAREK R ELHAMAKY</last_name>
    <role>Principal Investigator</role>
    <affiliation>Benha university faculty of medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>INMC</name>
      <address>
        <city>Abu Dhabi</city>
        <zip>46266</zip>
        <country>United Arab Emirates</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Arab Emirates</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>February 11, 2020</study_first_submitted>
  <study_first_submitted_qc>February 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2020</study_first_posted>
  <last_update_submitted>May 28, 2020</last_update_submitted>
  <last_update_submitted_qc>May 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benha University</investigator_affiliation>
    <investigator_full_name>Tarek Roshdy mohamed Mahgoub ELhamaky</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <keyword>adenoviral</keyword>
  <keyword>infiltrates</keyword>
  <keyword>PTK</keyword>
  <keyword>tacrolimus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tacrolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

